Affygility Solutions is pleased to announce that three new OEL Fastrac monographs have been posted up to the oelfastrac.com system. These three new OEL Fastrac monographs contain both the occupational exposure limit (OEL) and the acceptable daily exposure value (ADE). The 3 new OEL Fastrac monographs include:
- Access: Unsurpassed convenience. These documents are available to pharmaceutical companies and contract manufacturers throughout the world. Once payment is processed, OEL Fastrac monographs are available for instant download.
- Affordability: Similar occupational exposure limit (OEL) and acceptable daily exposure (ADE) documents obtained through traditional consulting means costs 7-10 times more.
- Authoritative: OEL Fastrac monographs are prepared by pharmaceutical industry experts with advanced degrees, professional certifications, and decades of pharmaceutical industry experience.
- Accelerative: Unsurpassed delivery with instant download.
Don’t see your compound in the catalog? No problem. For an additional fee, the occupational toxicology experts at Affygility Solutions can prepare a custom OEL Fastrac monograph containing both the occupational exposure limit and acceptable daily exposure value, or for early stage compounds we can prepare a potent compound categorization report. Contact us today for further information.
Have a proprietary or novel compound? No problem. We have worked with hundreds of pharmaceutical and contract manufacturers in developing OELs and ADEs for proprietary and novel compounds. These monographs are then consider confidential and proprietary information and are never published to our catalog. Contact us today for further information.
To learn more, and search our catalog of OEL Fastrac monographs, go to oelfastrac.com.
Affygility Solutions provides EHS software, occupational toxicology, potent compound safety, EHS training, industrial hygiene, containment validation, and other EHS services to the biotechnology, pharmaceutical, medical device, and contract manufacturing industries.